Pharmacological modification of glutamate neurotoxicity in vivo
Authors:
- 26 November 1993
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 629 (1) , 73-78
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Limiting Ischemic Injury by Inhibition of Excitatory Amino Acid ReleaseJournal of Cerebral Blood Flow & Metabolism, 1993
- A novel neuronal messenger molecule in brain: The free radical, nitric oxideAnnals of Neurology, 1992
- Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemiaNeuroscience Letters, 1992
- The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemiaBritish Journal of Pharmacology, 1992
- Protection against ischemic hippocampal CAI damage in the rat with a new non-NMDA antagonist, NBQXActa Neurologica Scandinavica, 1992
- The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia modelBrain Research, 1992
- The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemiaBrain Research, 1992
- Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult ratsNeuroscience Letters, 1991
- The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult ratsJournal of Neuroscience, 1991
- New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neuronsNeuroscience Letters, 1988